JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 50:146-148, doi:10.1016/j.jacc.2007.04.028 (Published online 21 May 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kastrati, A.
Right arrow Articles by Schömig, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kastrati, A.
Right arrow Articles by Schömig, A.

Drug-Eluting Stents

Is Their Future as Bright as Their Past?*

Adnan Kastrati, MD1,* and Albert Schömig, MD2

Deutsches Herzzentrum, Technische Universität, Munich, Germany.


Figure 1
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 RRs for Stent Thrombosis in 17 Randomized Trials Comparing SES With BMS

The source of the trials may be found in Kastrati et al. (7). BMS = bare-metal stent; CI = confidence interval; FU = follow-up; RR = relative risk; SES = sirolimus-eluting stent.

 

Figure 2
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 RRs for Death in 17 Randomized Trials Comparing SES With BMS

The source of the trials may be found in Kastrati et al. (7). Abbreviations as in Figure 1.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.